Why the study?
Does the treatment of perioperative hypertension with newer agents affect long-term patient outcomes?
Does the treatment of perioperative hypertension with newer agents affect long-term patient outcomes?
While newer agents like nicardipine and fenoldopam offer potential advantages for perioperative hypertension, there remains a lack of large-scale data demonstrating their impact on long-term outcomes.
No takes yet. Share an insight, caveat, or question.
Supports cautious perioperative hypertension management without proven long-term benefits; leaves open whether newer agents improve outcomes.
Goldberg et al. (1998) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: